v3.19.3
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2019
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:      
Net income (loss) $ (90,248) $ 8,630 $ (122,624)
Adjustments to reconcile net income (loss):      
Depreciation and amortization 25,102 40,720 83,205
(Gain) loss on disposition of assets, net (384) 145 126
Reorganization items 62,470 0 0
Deferred tax expense (benefit) (1,685) 5,202 (546)
Loss on impairment 0 0 43,990
Expenses not requiring cash 2,575 6,186 4,491
Change in assets and liabilities:      
Accounts and notes receivable (32,842) 939 (15,646)
Other assets (6,542) (7,482) 7,678
Accounts payable and accrued liabilities 55,780 (19,393) (3,866)
Accrued income taxes 688 (1,329) (324)
Net cash provided by (used in) operating activities 14,914 33,618 (3,516)
Cash flows from investing activities:      
Capital expenditures (9,231) (46,738) (52,020)
Proceeds from the sale of assets 101 374 1,031
Net cash provided by (used in) investing activities (9,130) (46,364) (50,989)
Cash flows from financing activities:      
Payment of term loan 0 (35,158) 0
Payments of debt issuance costs (490) (275) (1,443)
Proceeds from rights offering 95,000 0 0
Payment of amounts borrowed under debtor in possession financing (10,000) 0 0
Predecessor preferred stock dividend 0 0 (3,625)
Shares surrendered in lieu of tax 0 0 (248)
Net cash provided by (used in) financing activities 84,510 (35,433) (5,316)
Net increase (decrease) in cash and cash equivalents and restricted cash 90,294 (48,179) (59,821)
Cash and cash equivalents and restricted cash at beginning of period 58,991 149,285 141,549
Cash and cash equivalents and restricted cash at end of period $ 149,285 $ 101,106 $ 81,728

Source